ETFs/HQL
HQL
$16.46

TEKLA LIFE SCIENCES INVESTORS

AUM$384M
Holdings96
FundXLS
See EXACTLY what you own with FundXLS
Unlock all holdings, sector analysis, peer comparison & more
View Plans

Fund Essentials

Net Assets
$384M
Expense Ratio
-
Dividend Yield
-
Holdings
0
Inception Date
-
Fund Family
TEKLA LIFE SCIENCES INVESTORS
Asset Class
••••••••••
Legal Structure
••••••••••

Performance

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
REGNRegeneron Pharmaceuticals Inc7.35%
AMGNAmgen Inc7.28%
GILDGilead Sciences Inc6.61%
VRTXVertex Pharmaceuticals Inc4.53%
ALNYAlnylam Pharmaceuticals Inc3.45%
Top 10 Concentration: 42.75%

Peer Comparison

Peer Category
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Category Avg
+••.••%
Benchmark
•••••••••• (•••)
Premium Feature
Sign in to unlock peer comparison, category rankings and more
1 Month
+16.37%
YTD
+16.18%
1 Year
+16.18%
3 Year
+52.69%

Top 10 Holdings (42.7% of portfolio)

#TickerNameSectorWeight
1REGNRegeneron Pharmaceuticals IncManufacturing7.35%
2AMGNAmgen IncManufacturing7.28%
3GILDGilead Sciences IncManufacturing6.61%
4VRTXVertex Pharmaceuticals IncManufacturing4.53%
5ALNYAlnylam Pharmaceuticals IncManufacturing3.45%
6BMRNBioMarin Pharmaceutical IncManufacturing3.44%
7GVMXXState Street Institutional US Government Money Market FundUnknown2.92%
8IM8NInsmed IncUnknown2.42%
9ARGXARGENX SEManufacturing2.41%
10BNTXBioNTech SEManufacturing2.34%